Følg
Joshua T. Lange
Joshua T. Lange
Verifisert e-postadresse på ucsd.edu
Tittel
Sitert av
Sitert av
År
ecDNA hubs drive cooperative intermolecular oncogene expression
KL Hung, KE Yost, L Xie, Q Shi, K Helmsauer, J Luebeck, R Schöpflin, ...
Nature 600 (7890), 731-736, 2021
1422021
AmpliconReconstructor integrates NGS and optical mapping to resolve the complex structures of focal amplifications
J Luebeck, C Coruh, SR Dehkordi, JT Lange, KM Turner, V Deshpande, ...
Nature communications 11 (1), 4374, 2020
602020
The evolutionary dynamics of extrachromosomal DNA in human cancers
JT Lange, JC Rose, CY Chen, Y Pichugin, L Xie, J Tang, KL Hung, ...
Nature genetics 54 (10), 1527-1533, 2022
552022
Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient …
RJ Allaway, DA Fischer, FB De Abreu, TB Gardner, SR Gordon, RJ Barth, ...
Oncotarget 7 (13), 17087, 2016
482016
Principles of ecDNA random inheritance drive rapid genome change and therapy resistance in human cancers
JT Lange, CY Chen, Y Pichugin, L Xie, J Tang, KL Hung, KE Yost, Q Shi, ...
BioRxiv, 2021.06. 11.447968, 2021
162021
The landscape of extrachromosomal circular DNA in medulloblastoma
OS Chapman, J Luebeck, S Wani, A Tiwari, M Pagadala, S Wang, ...
bioRxiv, 2021.10. 18.464907, 2021
102021
Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma
OS Chapman, J Luebeck, S Sridhar, ITL Wong, D Dixit, S Wang, G Prasad, ...
Nature genetics 55 (12), 2189-2199, 2023
22023
Tumors driven by oncogene amplified extrachromosomal DNA (ecDNA) demonstrate enhanced sensitivity to cell cycle checkpoint kinase 1 (CHK1) inhibition
S Chowdhry, S Milutinovic, E Tse, S Garcia, D Perusse, M Ritland, J Ko, ...
Cancer Research 83 (7_Supplement), 1626-1626, 2023
22023
Oral CHK1 inhibitor BBI-355 allows flexibility of dose and schedule with demonstration of monotherapy and combinational antitumor activity in extrachromosomal DNA (ecDNA …
RJ Hansen, A Steffy, J Plum, A Ardeshiri, E Tse, S Garcia, B Norman, ...
Cancer Research 84 (6_Supplement), 613-613, 2024
2024
A novel, potent and selective ribonucleotide reductase (RNR) inhibitor, BBI-825, blocks extrachromosomal DNA (ecDNA) amplification-mediated resistance to KRAS G12C inhibitor in …
S Chowdhry, R Hansen, J Mauger, AM Pferdekamper, E Tse, B Norman, ...
MOLECULAR CANCER THERAPEUTICS 22 (12), 2023
2023
Coordinated inheritance of extrachromosomal DNA species in human cancer cells
KL Hung, MG Jones, ITL Wong, JT Lange, J Luebeck, E Scanu, BJ He, ...
bioRxiv, 2023
2023
Abstract B082: A novel, potent and selective ribonucleotide reductase (RNR) inhibitor, BBI-825, blocks extrachromosomal DNA (ecDNA) amplification-mediated resistance to …
S Chowdhry, R Hansen, J Mauger, AM Pferdekamper, E Tse, B Norman, ...
NaN, B082-B082, 2023
2023
Deciphering the evolutionary dynamics of extrachromosomal DNA in human cancer
JT Lange, PS Mischel
NATURE GENETICS 54 (10), 1455-1455, 2022
2022
The evolutionary dynamics of extrachromosomal DNA in human cancers
JT Lange, JC Rose, CY Chen, Y Pichugin, L Xie, J Tang, KL Hung, ...
Nature Genetics, 1-7, 2022
2022
Cancer Being Extra: Extrachromosomal DNA Promotes Heterogeneity and Resistance in Cancer
JT Lange
University of California, San Diego, 2022
2022
Entwicklung des Missbrauchs psychotroper Pflanzen und Pilze in Deutschland–Interpretation der Zahlen aus 3 Giftinformationszentren für die Jahre 2007–2013
J Pietsch, K Scheffel, D Acquarone, I Koch, M Deters, ...
Das Gesundheitswesen 43 (06), 532-539, 2018
2018
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–16